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Introduction : CHH is a genetic syndrome that combines reproductive and brain abnormalities. The brain 
phenotype has been incompletely characterized. We aimed to study neuroradiological and genetic features in this 
first Belgian cohort of patients with CHH. 
Patients and methods:.  
A series of 56 adult patients (48 males, 8 females) presenting with CHH was investigated for a panel of 16 genes 
related to hypogonadotropic hypogonadism  by next generation sequencing on a MiSeq® Instrument (Illumina) 
and by using a validated targeted approach with xGen® Lockdown® Probes (IDT). We then reviewed cerebral  or 
hypothalamic-pituitary abnormalities in 32 patients using  magnetic resonance image (MRI). 
 
Results. Among the 56 patients, we found, until now, some 26 genetic variants including FGFR1, GnRHR, 
CHDT, TAC3, WDR11, HS6ST1, PROKR2 and KISSR genes. 
In this series, five new variants (class3 to 5) were present in the following genes: TAC3 gene (c.238+1 G>A, class 
5),  FGFR1 gene (c.169C>A, p.Leu57Met, class 3), CDH7 gene (c.7212_7214del,p.Arg2405del, class 3), KISS1R 
(c.502G>A, p.Val168IIe, class 3) and a deletion of KISSR. 
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Discussion:  In our cohort, CM1 was found in three of the 32 patients (9.3%) who performed a brain MRI. In the general 
population, incidence of CM1 is estimated at 0,7%. CM1 and CHH have not been previously reported, although CM1 and  
cerebellar herniation were seen in GHD or in multiple hormone deficiency patients. We found a new FGFR1 mutation for one 
of our patients with CM1. Common variants in genes involved in somitogenesis and fetal vascular development may confer a 
susceptibility for CM1: the contribution of FGFR1 to these defects deserve more investigations. 
Conclusions: In this largest Belgian series of CHH, we describe for the first time five new  pathogenic variants. Moreover, 
we suggest a new syndromic association between CHH and CM1. Multicenter studies and systematic brain MRI may be 
required to extend the phenotype and the genotype of CHH patients. 
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